Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism BCL6 inhibitors(B-cell lymphoma 6 protein inhibitors), CDK9 inhibitors(Cyclin-dependent kinase 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Discovery | United States | 09 Dec 2024 |